Scientists uncover protein that thwarts tumor invasion

Jun 07, 2010

Researchers at UT Southwestern Medical Center have determined that cancer cells lacking a key protein are more invasive and more likely to metastasize, providing a possible drug target to combat certain tumor types.

"Further down the line we could create a drug that would bring COMMD1 levels back to normal, or even above normal, in the tumor to hopefully affect cancer cell invasion," said Dr. Ezra Burstein, assistant professor of internal medicine and and senior author of the study appearing in the June issue of the . "If the cancer cells have already started invading other organs, maybe further invasion would be halted or even regressed."

Dr. Burstein is a member of a research team that years ago discovered the COMMD family of proteins and its abilities. They discovered that one of those proteins, COMMD1, inhibits NF-kB, a key factor that activates genes involved in inflammation and that is often involved in helping cancer cells survive. COMMD1 also regulates a protein called HIF, which plays a role in the survival of cells in areas of low oxygen, a common feature of cancer. For example, enhanced HIF activity is associated with , metastasis and poor clinical outcomes for cancer patients.

Because COMMD1 has this dual role in regulating both NF-kB and HIF, the researchers thought that COMMD1 might be inactivated or repressed in tumors. This study supports their hypothesis, as the scientists found decreased amounts of this protein in a variety of human cancers and the decreased expression of COMMD1 also was associated with more invasive cancers.

COMMD1 suppression in cancer cells leads to enhanced activity of both NF-kB and HIF, a one-two punch that makes the cancer more invasive, Dr. Burstein said.

In a review of 63 patients with endometrial cancer, the researchers determined that those whose tumors had the lowest levels of COMMD1 had the worst clinical outcomes.

Using mice, it was also discovered that the COMMD1-deficient cells were more invasive when implanted. The researchers then generated mouse melanoma cells that produced an overabundance of COMMD1, and injected those cells back into healthy mice. The number of metastatic lung tumors that resulted was greatly reduced when the cells expressed greater levels of COMMD1.

These results indicate that COMMD1 restrains the metastatic potential of an invasive cancer cell line, Dr. Burstein said.

"This is the first study that clearly links COMMD1 to human disease and substantiates what we would've expected based on the prior work we have done on this protein," he said. "COMMD1 is yet another player in the very important and complicated cancer invasion process."

The next step, Dr. Burstein said, will be to investigate what changes in the tumor environment may be responsible for reducing levels of COMMD1 in .

Explore further: Two studies identify a detectable, pre-cancerous state in the blood

add to favorites email to friend print save as pdf

Related Stories

FOXO factor promotes survival of oxygen-deprived cancer cells

Dec 27, 2007

Scientists report that an evolutionarily conserved transcription factor may have both positive and negative effects on the growth of tumors, depending on whether or not the tumor cells have enough oxygen. The research, published ...

Researchers find clue to stopping breast-cancer metastasis

Nov 17, 2008

If scientists knew exactly what a breast cancer cell needs to spread, then they could stop the most deadly part of the disease: metastasis. New research from the University of North Carolina at Chapel Hill School of Medicine ...

Recommended for you

Hospital volume not linked to costs of cancer surgery

2 hours ago

(HealthDay)—Hospital surgical volume does not appear to correlate with Medicare payments for cancer surgery, according to research published online Nov. 24 in the Journal of Clinical Oncology.

How a common antacid could lead to cheaper anti-cancer drugs

4 hours ago

A popular indigestion medication can increase survival in colorectal cancer, according to research published in ecancermedicalscience. But in fact, scientists have studied this for years - and a group of cancer advocates want t ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.